These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 21722781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medical therapy for peripheral arterial disease.
    Simmons A, Steffen K, Sanders S.
    Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
    [Abstract] [Full Text] [Related]

  • 3. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe.
    Morrell J, Zeymer U, Baumgartner I, Limbourg T, Röther J, Bhatt DL, Steg PG, REACH Registry Investigators.
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):270-7. PubMed ID: 20606595
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL, Fitridge R, Dawson J, Nicholls SJ.
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [Abstract] [Full Text] [Related]

  • 6. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B, Barreto-Filho JA.
    Circ Cardiovasc Qual Outcomes; 2012 Jul 01; 5(4):580-6. PubMed ID: 22811501
    [No Abstract] [Full Text] [Related]

  • 7. Non-Invasive Therapy of Peripheral Arterial Disease.
    Marcial JM, Pérez R, Vargas P, Franqui-Rivera H.
    Bol Asoc Med P R; 2015 Jul 01; 107(3):52-7. PubMed ID: 26742197
    [Abstract] [Full Text] [Related]

  • 8. Performance measures in million hearts: 2 partners' perspective.
    Drozda JP, Holmes DP.
    Circ Cardiovasc Qual Outcomes; 2012 Jul 01; 5(4):587-8. PubMed ID: 22811502
    [No Abstract] [Full Text] [Related]

  • 9. Contemporary and optimal medical management of peripheral arterial disease.
    Tattersall MC, Johnson HM, Mason PJ.
    Surg Clin North Am; 2013 Aug 01; 93(4):761-78, vii. PubMed ID: 23885930
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ, van Hattum ES.
    Thromb Haemost; 2010 Aug 01; 104(2):196-9. PubMed ID: 20508897
    [No Abstract] [Full Text] [Related]

  • 11. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U, EUROASPIRE Study Group.
    Eur J Cardiovasc Prev Rehabil; 2010 Oct 01; 17(5):530-40. PubMed ID: 20577089
    [Abstract] [Full Text] [Related]

  • 12. Nurse-coordinated care in CKD: time for translation into practice?
    Smith DH, Thorp ML.
    Clin J Am Soc Nephrol; 2011 Jun 01; 6(6):1229-31. PubMed ID: 21617089
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF, Stolcpart RS, Hollis HW, Society for Vascular Surgery.
    J Vasc Surg; 2008 May 01; 47(5):1108-15. PubMed ID: 18372155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW, Jaff MR.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):475-89. PubMed ID: 18307227
    [Abstract] [Full Text] [Related]

  • 17. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B, Henriksson M, Lundin F, Wahlberg E.
    Eur J Cardiovasc Prev Rehabil; 2011 Apr 01; 18(2):254-61. PubMed ID: 21450673
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar 01; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR.
    J Vasc Surg; 2002 Dec 01; 36(6):1283-91. PubMed ID: 12469066
    [Abstract] [Full Text] [Related]

  • 20. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL.
    Dan Med J; 2012 Sep 01; 59(9):B4514. PubMed ID: 22951205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.